Bruce Jackson

Stock Analyst at Benchmark

(0.92)
# 3,782
Out of 4,902 analysts
123
Total ratings
27.12%
Success rate
-25.31%
Average return

Stocks Rated by Bruce Jackson

Biofrontera
May 19, 2025
Maintains: Buy
Price Target: $7$2.75
Current: $0.85
Upside: +223.15%
Humacyte
May 14, 2025
Maintains: Buy
Price Target: $17$14
Current: $2.42
Upside: +478.51%
Harvard Bioscience
May 13, 2025
Maintains: Speculative Buy
Price Target: $4.5$3
Current: $0.45
Upside: +560.94%
Clene
May 8, 2025
Maintains: Buy
Price Target: $84$33
Current: $3.90
Upside: +746.15%
Genelux
May 8, 2025
Maintains: Speculative Buy
Price Target: $25$23
Current: $3.40
Upside: +576.47%
Belite Bio
Mar 26, 2025
Reiterates: Buy
Price Target: $80
Current: $60.99
Upside: +31.17%
NeoGenomics
Jan 16, 2025
Reiterates: Hold
Price Target: n/a
Current: $6.72
Upside: -
Exact Sciences
Jan 13, 2025
Reiterates: Buy
Price Target: $65
Current: $52.21
Upside: +24.50%
VolitionRx
Nov 22, 2024
Reiterates: Hold
Price Target: n/a
Current: $0.68
Upside: -
Unicycive Therapeutics
Nov 22, 2024
Reiterates: Speculative Buy
Price Target: $30
Current: $4.65
Upside: +545.16%
Reiterates: Speculative Buy
Price Target: $1.25
Current: $0.63
Upside: +99.08%
Reiterates: Speculative Buy
Price Target: $3
Current: $1.34
Upside: +123.88%
Reiterates: Speculative Buy
Price Target: $5
Current: $2.00
Upside: +150.00%
Reiterates: Speculative Buy
Price Target: $30
Current: $0.62
Upside: +4,738.71%
Reiterates: Speculative Buy
Price Target: $60
Current: $4.62
Upside: +1,198.70%
Reiterates: Speculative Buy
Price Target: $17
Current: $0.41
Upside: +4,095.46%
Reiterates: Speculative Buy
Price Target: $24
Current: $1.08
Upside: +2,122.22%
Reiterates: Speculative Buy
Price Target: $1
Current: $2.65
Upside: -62.26%
Reiterates: Speculative Buy
Price Target: $5
Current: $0.69
Upside: +622.54%
Downgrades: Hold
Price Target: n/a
Current: $1.66
Upside: -
Downgrades: Hold
Price Target: n/a
Current: $17.28
Upside: -
Initiates: Speculative Buy
Price Target: $800
Current: $4.16
Upside: +19,130.77%